insulin sensitizers (Lipha)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameinsulin sensitizers (Lipha)
Drug Alias NameCRE-16258CRE-17815
ClassificationSmall molecules
Mechanisms of ActionInsulin sensitizers
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sante Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sante Sas
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A